Clinical Trial

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Study acronym: NoCUT-BC
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study will evaluate the efficacy and non-inferiority of a non-surgical approach for the treatment of patients with locally advanced breast cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-15; most recent amendment 2026-06-20.
Trial Details
NCT Number NCT07217990
Lead Sponsor Ohio State University Comprehensive Cancer Center
Collaborators: Gateway for Cancer Research
Conditions Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer
Enrollment 84 participants
Start Date 2026-09-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-24